Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.28 USD
Change Today +0.0155 / 5.92%
Volume 1.2M
As of 8:04 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

inspiremd inc (NSPR) Snapshot

Open
$0.28
Previous Close
$0.26
Day High
$0.29
Day Low
$0.26
52 Week High
06/20/14 - $3.25
52 Week Low
03/11/15 - $0.23
Market Cap
21.7M
Average Volume 10 Days
718.8K
EPS TTM
$-0.72
Shares Outstanding
78.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSPIREMD INC (NSPR)

Related News

No related news articles were found.

inspiremd inc (NSPR) Related Businessweek News

No Related Businessweek News Found

inspiremd inc (NSPR) Details

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing PVGuard for use in peripheral vascular applications. It operates in the Middle East, Germany, Belarus, Spain, the Russian Federation, and internationally. The company is headquartered in Boston, Massachusetts.

55 Employees
Last Reported Date: 03/12/15

inspiremd inc (NSPR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $519.1K
Chief Financial Officer, Chief Administrative...
Total Annual Compensation: $236.9K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $194.7K
Chief Technology Officer, Chief Technical Off...
Total Annual Compensation: $201.7K
Compensation as of Fiscal Year 2014.

inspiremd inc (NSPR) Key Developments

InspireMD Plan Of Compliance Accepted By NYSE MKT

InspireMD, Inc. announced that the New York Stock Exchange has accepted InspireMD's plan to regain compliance with the NYSE MKT's market capitalization continued listing standards. As previously disclosed, the NYSE notified the Company on January 20, 2015 that it had fallen below the NYSE's continued listing standards. Based upon a review of the compliance plan and information submitted by the Company, the Exchange determined that the Company made a reasonable demonstration of its ability to make substantial progress toward regaining compliance with Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the Company Guide by July 20, 2016. The Exchange also determined that the Company has resolved the continued listing deficiency with respect to Section 1003(a)(iv) of the Company Guide. The Company will be subject to periodic review by the exchange staff during the period covered by the plan. Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the plan period could result in the Company's shares being delisted from the Exchange.

InspireMD, Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

InspireMD, Inc. announced consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company announced revenue of $0.870 million compared to $1.553 million a year ago. Loss from operations was $4.447 million compared to $4.942 million a year ago. Loss before tax expenses was $4.781 million compared to $5.384 million a year ago. Net loss was $4.790 million or $0.12 per basic and diluted share compared to $5.391 million or $0.16 per basic and diluted share a year ago. Non-GAAP net loss was $3.763 million or $0.09 per basic and diluted share compared to $4.549 million or $0.13 per basic and diluted share a year ago. The 2014 period included an expected decline in sales volume associated with the limited resumption of sales activity following the temporary stoppage of sales activities for the MGuard Prime EPS following voluntary field action (VFA). For the year, the company announced revenue of $2.818 million compared to $6.119 million a year ago. Loss from operations was $23.698 million compared to $16.253 million a year ago. Loss before tax expenses was $25.083 million compared to $29.199 million a year ago. Net loss was $25.095 million or $0.71 per basic and diluted share compared to $29.168 million or $0.86 per basic and diluted share a year ago. Non-GAAP net loss was $20.904 million or $0.59 per basic and diluted share compared to $12.803 million or $0.38 per basic and diluted share a year ago. The 2014 period included a decline in sales volume associated with the temporary stoppage of sales activities for the MGuard Prime EPS following VFA.

InspireMD, Inc. to Report Q4, 2014 Results on Mar 12, 2015

InspireMD, Inc. announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Mar 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NSPR:US $0.28 USD +0.0155

NSPR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.49 USD -0.83
Boston Scientific Corp $17.98 USD -0.36
Johnson & Johnson $100.58 USD -0.50
Medtronic PLC $76.21 USD -1.40
Sorin SpA €2.90 EUR +0.002
View Industry Companies
 

Industry Analysis

NSPR

Industry Average

Valuation NSPR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSPIREMD INC, please visit www.inspire-md.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.